Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Exosens doubles cooled infrared camera production to meet rising demand in counter-drone systems.

Market News
20 May 2026
Exosens
View Source
Bullish
pluang ai news

Exosens plans to double its production capacity for cooled infrared cameras in 2026 to meet growing global demand, especially for long-range surveillance and counter-drone applications. These cameras, made in France, are critical for detecting drone threats at long distances, day and night, and are increasingly used by defense contractors and autonomous system developers. This expansion highlights Exosens' strategic role in defense and homeland security markets and its ability to scale production to support evolving operational needs. The move follows a record order for thermal cameras for next-gen interceptor drones, reinforcing confidence in the long-term growth of cooled infrared technology in defense.

More News

Farm Progress Show 2026 in Iowa unveils new Agronomy Zone, premium tickets, and Drone Zone for farmers

Farm Progress Show 2026 in Iowa unveils new Agronomy Zone, premium tickets, and Drone Zone for farmers

The Farm Progress Show 2026, held in Boone, Iowa from Sept. 1-3, introduces three major innovations: an expanded Agronomy Zone with research-grade crop plots and expert tours, new $60 premium ticket packages including admission, a hat, and lunch vouc...

Others
Bullish
1 hour ago
Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...

Market News
Bullish
2 hours ago
ADARx to present Phase 1/2 data on Onvuzosiran for hereditary angioedema at 2026 EAACI Congress

ADARx to present Phase 1/2 data on Onvuzosiran for hereditary angioedema at 2026 EAACI Congress

ADARx Pharmaceuticals announced it will present Phase 1/2 clinical data for Onvuzosiran, an RNA therapy for hereditary angioedema (HAE), at the 2026 EAACI Congress in Istanbul. Onvuzosiran targets plasma prekallikrein to prevent swelling attacks by r...

Market News
Bullish
2 hours ago
FDH Aero secures majority investment from Bain Capital to boost global aerospace supply chain growth

FDH Aero secures majority investment from Bain Capital to boost global aerospace supply chain growth

FDH Aero, a leading aerospace and defense supply chain provider, has agreed to a majority investment from Bain Capital Private Equity, with Audax Private Equity remaining a significant investor. This partnership aims to accelerate FDH's growth strate...

Company Fundamentals
Bullish
2 hours ago
Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App